Lamez OD 25 Tablet SR contains Lamotrigine 25 mg, an antiepileptic medication primarily indicated for the management of epilepsy and bipolar disorder. Lamotrigine acts by stabilizing neuronal membranes and modulating voltage-sensitive sodium channels, thereby inhibiting the release of excitatory neurotransmitters such as glutamate and aspartate. This mechanism helps in controlling seizures and mood episodes. Lamez OD 25 Tablet SR is formulated as a sustained-release preparation to provide a consistent plasma concentration, improving therapeutic efficacy and reducing dosing frequency. It is commonly prescribed for partial seizures, generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome. Additionally, it is effective in the maintenance treatment of bipolar disorder to delay the occurrence of mood episodes. The medication should be initiated at a low dose with gradual titration to minimize the risk of serious adverse reactions such as Stevens-Johnson syndrome and other hypersensitivity reactions. Common side effects may include dizziness, headache, blurred vision, and gastrointestinal disturbances. Caution is advised in patients with a history of hypersensitivity to lamotrigine or other anticonvulsants. Regular monitoring and adherence to prescribed dosing schedules are essential to optimize therapeutic outcomes and minimize risks.